{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:53:56Z","timestamp":1787025236272,"version":"build-2736575974"},"reference-count":62,"publisher":"Edizioni Minerva Medica","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["G Ital Dermatol Venereol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.23736\/s0392-0488.20.06643-2","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T10:48:35Z","timestamp":1602586115000},"source":"Crossref","is-referenced-by-count":18,"title":["Tofacitinib for the treatment of psoriasis and psoriatic arthritis"],"prefix":"10.23736","volume":"155","author":[{"given":"Arvin","family":"Ighani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge R.","family":"Georgakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jensen","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17149","reference":[{"key":"10.23736\/S0392-0488.20.06643-2_ref001","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13854"},{"key":"10.23736\/S0392-0488.20.06643-2_ref002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.02.039"},{"key":"10.23736\/S0392-0488.20.06643-2_ref003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.12.018"},{"key":"10.23736\/S0392-0488.20.06643-2_ref004","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0169-x"},{"key":"10.23736\/S0392-0488.20.06643-2_ref005","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.06.027"},{"key":"10.23736\/S0392-0488.20.06643-2_ref006","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032482"},{"key":"10.23736\/S0392-0488.20.06643-2_ref007","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/539683"},{"key":"10.23736\/S0392-0488.20.06643-2_ref008","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120225"},{"key":"10.23736\/S0392-0488.20.06643-2_ref009","first-page":"278","article-title":"Diagnosis and management of psoriasis","volume":"63","author":"Kim WB","year":"2017","journal-title":"Can Fam Physician"},{"key":"10.23736\/S0392-0488.20.06643-2_ref010","doi-asserted-by":"publisher","DOI":"10.1177\/2040622315582354"},{"key":"10.23736\/S0392-0488.20.06643-2_ref011","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5264"},{"key":"10.23736\/S0392-0488.20.06643-2_ref012","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13150"},{"key":"10.23736\/S0392-0488.20.06643-2_ref013","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.826341"},{"key":"10.23736\/S0392-0488.20.06643-2_ref014","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102390"},{"key":"10.23736\/S0392-0488.20.06643-2_ref015","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12265"},{"key":"10.23736\/S0392-0488.20.06643-2_ref016","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1512404"},{"key":"10.23736\/S0392-0488.20.06643-2_ref017","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003668"},{"key":"10.23736\/S0392-0488.20.06643-2_ref018","first-page":"318","article-title":"The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis","volume":"34","author":"Hodge JA","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.23736\/S0392-0488.20.06643-2_ref019","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key225"},{"key":"10.23736\/S0392-0488.20.06643-2_ref020","unstructured":"FDA declines to expand approval of Pfizer arthritis drug. Reuters; 2015 [Internet]. Available from: https:\/\/www.reuters.com\/article\/pfizer-psoriasis-fda-idUSL1N12E2OW20151014 [cited 2020, Feb 26]"},{"key":"10.23736\/S0392-0488.20.06643-2_ref021","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14018"},{"key":"10.23736\/S0392-0488.20.06643-2_ref022","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62113-9"},{"key":"10.23736\/S0392-0488.20.06643-2_ref023","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13551"},{"key":"10.23736\/S0392-0488.20.06643-2_ref024","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.01.013"},{"key":"10.23736\/S0392-0488.20.06643-2_ref025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615975"},{"key":"10.23736\/S0392-0488.20.06643-2_ref026","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615977"},{"key":"10.23736\/S0392-0488.20.06643-2_ref027","first-page":"1010","article-title":"SAT0293 Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, up to 36 months in patients with active psoriatic arthritis: data from the third interim analysis of opal balance, an open-label, long-term extension study","volume":"77","author":"Nash P","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.23736\/S0392-0488.20.06643-2_ref028","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08315.x"},{"key":"10.23736\/S0392-0488.20.06643-2_ref029","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.03.049"},{"key":"10.23736\/S0392-0488.20.06643-2_ref030","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14164"},{"key":"10.23736\/S0392-0488.20.06643-2_ref031","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010858"},{"key":"10.23736\/S0392-0488.20.06643-2_ref032","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304070-00006"},{"key":"10.23736\/S0392-0488.20.06643-2_ref033","doi-asserted-by":"publisher","DOI":"10.12788\/j.sder.0069"},{"key":"10.23736\/S0392-0488.20.06643-2_ref034","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06174.x"},{"key":"10.23736\/S0392-0488.20.06643-2_ref035","doi-asserted-by":"publisher","DOI":"10.3109\/09546630903085328"},{"key":"10.23736\/S0392-0488.20.06643-2_ref036","first-page":"S63","article-title":"Continuous versus intermittent therapy for moderate-to-severe psoriasis","volume":"31","author":"Ramirez-Fort MK","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.23736\/S0392-0488.20.06643-2_ref037","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.10139.x"},{"key":"10.23736\/S0392-0488.20.06643-2_ref038","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04515.x"},{"key":"10.23736\/S0392-0488.20.06643-2_ref039","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60725-4"},{"key":"10.23736\/S0392-0488.20.06643-2_ref040","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033486"},{"key":"10.23736\/S0392-0488.20.06643-2_ref041","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204655"},{"key":"10.23736\/S0392-0488.20.06643-2_ref042","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160275"},{"key":"10.23736\/S0392-0488.20.06643-2_ref043","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.02.007"},{"key":"10.23736\/S0392-0488.20.06643-2_ref044","doi-asserted-by":"publisher","DOI":"10.1002\/art.38745"},{"key":"10.23736\/S0392-0488.20.06643-2_ref045","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12370"},{"key":"10.23736\/S0392-0488.20.06643-2_ref046","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12307"},{"key":"10.23736\/S0392-0488.20.06643-2_ref047","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202442"},{"key":"10.23736\/S0392-0488.20.06643-2_ref048","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61424-X"},{"key":"10.23736\/S0392-0488.20.06643-2_ref049","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3899\/jrheum.190114","article-title":"Cardiovascular Diseases in Psoriasis and Psoriatic Arthritis","volume":"95","author":"Eder L","year":"2019","journal-title":"J Rheumatol Suppl"},{"key":"10.23736\/S0392-0488.20.06643-2_ref050","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23930"},{"key":"10.23736\/S0392-0488.20.06643-2_ref051","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.05.014"},{"key":"10.23736\/S0392-0488.20.06643-2_ref052","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket466"},{"key":"10.23736\/S0392-0488.20.06643-2_ref053","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310476"},{"key":"10.23736\/S0392-0488.20.06643-2_ref054","unstructured":"Research C for DE and. FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR). FDA; 2019 [Internet]. Available from: http:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-approves-boxed-warning-about-increased-risk-blood-clots-and-death-higher-dose-arthritis-and [cited 2020, Mar 17]"},{"key":"10.23736\/S0392-0488.20.06643-2_ref055","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10213.x"},{"key":"10.23736\/S0392-0488.20.06643-2_ref056","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06563.x"},{"key":"10.23736\/S0392-0488.20.06643-2_ref057","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.06.035"},{"key":"10.23736\/S0392-0488.20.06643-2_ref058","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-012-0037-5"},{"key":"10.23736\/S0392-0488.20.06643-2_ref059","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09505.x"},{"key":"10.23736\/S0392-0488.20.06643-2_ref060","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00702.x"},{"key":"10.23736\/S0392-0488.20.06643-2_ref061","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1657404"},{"key":"10.23736\/S0392-0488.20.06643-2_ref062","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.09.060"}],"container-title":["Giornale Italiano di Dermatologia e Venereologia"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R23Y2020N04A0400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T22:40:47Z","timestamp":1669156847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R23Y2020N04A0400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":62,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.23736\/s0392-0488.20.06643-2","relation":{},"ISSN":["0392-0488","1827-1820"],"issn-type":[{"value":"0392-0488","type":"print"},{"value":"1827-1820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}